We observed the regulation of ITGA5 by the mutp53/ENTPD5 axis across various clinically relevant cancer types, including pancreatic, lung, and breast cancer and for multiple different p53 missense mutants (Supplemental Fig. 1). This evidence concerns the gene TP53 and breast carcinoma.